牙周炎与非酒精性脂肪性肝病相关性的研究进展

摘要/Abstract

摘要： 非酒精性脂肪性肝病是一种常见的慢性肝病，可引起肝脏不同程度的病变，从脂肪变性、非酒精性脂肪性肝炎到纤维化，最终可发展为肝硬化和肝细胞癌。诸多研究表明，系统性炎症和肠道菌群失调可能参与该疾病的发生与发展。牙周炎作为细菌感染性疾病，可能通过牙周致病菌和炎症介质等方式调节机体的免疫炎症反应，影响肝脏健康。本文就目前牙周炎与非酒精性脂肪性肝病的相关性研究作一综述，期待从口腔医学视点为非酒精性脂肪性肝病的防治开辟新思路。

关键词: 牙周炎, 非酒精性脂肪性肝病, 免疫

Abstract: Nonalcoholic fatty liver disease is a common chronic liver disease that can cause liver lesions of varying degrees, from steatosis, nonalcoholic fatty hepatitis to fibrosis, and eventually cirrhosis and hepatocellular carcinoma. Many studies have shown that systemic inflammation and gut microbiota imbalance may be involved in the occurrence and development of this disease. As a local bacterial infectious disease, periodontitis may regulate the body through periodontal pathogenic bacteria and inflammatory mediators and affect the health of liver. This article reviews the current studies on the correlation between periodontitis and non-alcoholic fatty liver disease, expecting to provide a new prevention strategy from dental science viewpoint for NAFLD.

Key words: periodontitis, non-alcoholic fatty liver disease, immunity

中图分类号:

781.4

岳轶云丁小函刘东宁李艳夏博园于维先. 牙周炎与非酒精性脂肪性肝病相关性的研究进展[J]. 口腔医学, 2020, 40(1): 83-86.

参考文献 35

[1]	Adolph T E, Grander C, Moschen A R, et al.Liver–Microbiome Axis in Health and Disease[J].Trends in Immunology, 2018, 39(9):712-723
[2]	Qiao F, Fu K, Zhang Q, et al.The association between missing teeth and non-alcoholic fatty liver disease in adults[J].Journal of Clinical Periodontology, 2018, 45(8):941-951
[3]	Yoneda M, Naka S, Nakano K, et al.Involvement of a periodontal pathogen,Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease[J].BMC Gastroenterol, 2012, 12(1):16-25
[4]	Furuta M, Ekuni D, Yamamoto T, et al.Relationship between periodontitis and hepatic abnormalities in young adults[J].Acta Odontol Scand, 2010, 68(1):27-33
[5]	Komazaki R, Katagiri S, Takahashi H, et al.Periodontal pathogenic bacteria,Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism[J].Sci Rep, 2017, 7(1):13950-13950
[6]	Damgaard C, Holmstrup P, Van Dyke T E, et al.The complement system and its role in the pathogenesis of periodontitis: current concepts[J].Journal of Periodontal Research, 2015, 50(3):283-293
[7]	Benedyk M, Mydel PM, Delaleu N, et al.Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis[J].J Innate Immun, 2016, 8(2):185-98
[8]	Pockpa ZA, Struillou X, Coulibaly NT, et al.Potential relationship between periodontal diseases and eye diseases.[J].Med Hypotheses, 2017, 99(2):63-66
[9]	Hajishengallis G.Periodontitis: from microbial immune subversion to systemic inflammation[J].Nat Rev Immunol, 2015, 15(1):30-44
[10]	Varol C, Mildner A, Jung S.Macrophages: development and tissue specialization.[J].Annual review of immunology, 2015, 33(1):643-675
[11]	Cairo G, Recalcati S, Mantovani A, et al.Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype[J].Trends Immunol, 2011, 32(6):241-7
[12]	Molteni M, Bosi A, Rossetti C.The Effect of Cyanobacterial LPS Antagonist (CyP) on Cytokines and Micro-RNA Expression Induced by Porphyromonas gingivalis LPS[J].Toxins, 2018, 10(7):290-290
[13]	Zhang J, Yu C, Zhang X, et al.Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction,mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL6 mice[J].Journal of neuroinflammation, 2018, 15(1):37-37
[14]	Younossi Z, Anstee QM, Marietti M, et al.Global burden of NAFLD and NASH: trends,predictions,risk factors and prevention[J].Nat Rev Gastroenterol Hepatol, 2018, 15(1):11-20
[15]	Takaki A, Kawai D, Yamamoto K.Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)[J].International journal of molecular sciences, 2014, 15(5):7352-7379
[16]	Buzzetti E, Pinzani M, Tsochatzis EA.The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)[J].Metabolism, 2016, 65(8):1038-48
[17]	Tripathi A, Debelius J, Brenner DA, et al.The gut–liver axis and the intersection with the microbiome[J].Nat Rev Gastroenterol Hepatol, 2018, 15(7):397-411
[18]	Schuster S, Cabrera D, Arrese M, et al.Triggering and resolution of inflammation in NASH[J].Nat Rev Gastroenterol Hepatol, 2018, 15(6):349-364
[19]	Stefano Bibbò, Gianluca Ianiro, Maria Pina Dore, et al.Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease[J].Mediators Inflamm, 2018, 2018(6):1-7
[20]	Abdullah Z, Knolle P A.Liver macrophages in healthy and diseased liver[J].Pflügers Archiv-European Journal of Physiology, 2017, 469(3-4):553-560
[21]	Dixon L J, Barnes M, Tang H, et al.Kupffer cells in the liver[J].Comprehensive Physiology, 2013, 3(2):785-797
[22]	Li P, He K, Li J, et al.The role of Kupffer cells in hepatic diseases.[J].Molecular immunology, 2017, 85(1):222-229
[23]	Duarte N, Coelho I C, Patarr?o R S, et al.How inflammation impinges on NAFLD: a role for Kupffer cells. , , 2015.[J].BioMed research international, 2015, 984578(1):1-11
[24]	Wan J, Benkdane M, Teixeira-Clerc F, et al.M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease[J].Hepatology, 2014, 59(1):130-42
[25]	Lambertucci F, Arboatti A, Sedlmeier M G, et al.Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet. [J].The Journal of nutritional biochemistry, 2018, 58(1):17-27
[26]	Olsen I, Yilmaz.Modulation of inflammasome activity by Porphyromonas gingivalis in periodontitis and associated systemic diseases[J].J Oral Microbiol, 2016, 8(1):30385-30385
[27]	Fujita M, Kuraji R, Ito H, et al.Histological effects and pharmacokinetics of lipopolysaccharide derived from Porphyromonas gingivalis on rat maxilla and liver concerning with progression into non-alcoholic steatohepatitis.[J].Journal of Periodontology, 2018, 00(0):1-11
[28]	Vasconcelos A C C G, Vasconcelos D F P, Pereira da Silva F R, et al.Periodontitis causes abnormalities in the liver of rats[J].Journal of periodontology, 2019, 90(3):295-305
[29]	Renn T Y, Huang Y K, Feng S W, et al.Prophylactic Supplement with Melatonin Successfully Suppresses the Pathogenesis of Periodontitis through Normalizing RANKLOPG Ratio and Depressing the TLR4MyD88 Signaling Pathway[J].Journal of Pineal Research, 2017, 64(3):e12464-e12464
[30]	Cardoso EM, Reis C, Manzanares-Céspedes MC.Chronic periodontitis,inflammatory cytokines,and interrelationship with other chronic diseases[J].Postgrad Med, 2018, 130(1):98-104
[31]	Genco R J, Van Dyke T E.Prevention: Reducing the risk of CVD in patients with periodontitis[J].Nature Reviews Cardiology, 2010, 7(9):479-480
[32]	Ding Y, Ren J, Yu H, et al.Porphyromonas gingivalis,a periodontitis causing bacterium,induces memory impairment and age-dependent neuroinflammation in mice[J].Immun Ageing, 2018, 15(6):1-8
[33]	Clemente J C, Ursell L K, Parfrey L W, et al.The impact of the gut microbiota on human health: an integrative view[J].Cell, 2012, 148(6):1258-1270
[34]	Arimatsu K, Yamada H, Miyazawa H, et al.Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota.[J].Scientific Reports, 2014, 4(1):4828-4828
[35]	Nakajima M, Arimatsu K, Kato T, et al.Oral Administration of Pgingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver[J].Plos One, 2015, 10(7):e0134234-e0134234